Brief: Tarsus Strengthens Financial Position And Refinances Existing Debt With $200 Million Non-Dilutive Financing Commitment From Pharmakon
23/04/2024 13:55
April 23 (Reuters) - Tarsus Pharmaceuticals Inc
TARS.O :
* TARSUS STRENGTHENS FINANCIAL POSITION AND REFINANCES
EXISTING
DEBT WITH $200 MILLION NON-DILUTIVE FINANCING COMMITMENT FROM
PHARMAKON
* TARSUS PHARMACEUTICALS INC: STRENGTHENS FINANCIAL POSITION
AND
REFINANCES EXISTING DEBT WITH $200 MILLION NON-DILUTIVE
FINANCING COMMITMENT FROM PHARMAKON
Source text for Eikon: ID:nGNX6rbfCC
Further company coverage: TARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tarsus Pharmaceuticals
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Tarsus Pharmaceuticals Files For Offering Of Up To 2.91 Million Shares Of Common Stock By Selling Stockholders
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
Tarsus Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition (updated)